niacinamide has been researched along with Bullous Dermatoses in 14 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib is the standard treatment for patients with advanced hepatocellular carcinoma (HCC), although it is known to cause a variety of dermatologic adverse events." | 7.81 | Sneddon-Wilkinson disease induced by sorafenib in a patient with advanced hepatocellular carcinoma. ( Kawai, K; Minemura, M; Nakajima, T; Sugiyama, T; Tajiri, K, 2015) |
| "Pellagra is caused by a deficiency of nicotinamide or of its precursor tryptophan." | 5.30 | [Pellagra (deficiency of vitamin B3 or of the amino acid tryptophan): a disease still extant in the Netherlands]. ( Pasmans, SG; Preesman, AH; van Vloten, WA, 1998) |
| "Sorafenib is the standard treatment for patients with advanced hepatocellular carcinoma (HCC), although it is known to cause a variety of dermatologic adverse events." | 3.81 | Sneddon-Wilkinson disease induced by sorafenib in a patient with advanced hepatocellular carcinoma. ( Kawai, K; Minemura, M; Nakajima, T; Sugiyama, T; Tajiri, K, 2015) |
| " However, long-term use of these agents has drawbacks: steroids may induce numerous serious side effects such as hypertension, immunosuppression, and osteoporosis, and overuse of oral antibiotics may contribute to the development of bacterial resistance, as well as to a host of nuisance side effects such as diarrhea, yeast infections, and photosensitivity." | 2.43 | Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review. ( Niren, NM, 2006) |
| "Pellagra is caused by a deficiency of nicotinamide or of its precursor tryptophan." | 1.30 | [Pellagra (deficiency of vitamin B3 or of the amino acid tryptophan): a disease still extant in the Netherlands]. ( Pasmans, SG; Preesman, AH; van Vloten, WA, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamaguchi, Y | 1 |
| Oyama, N | 1 |
| Koizumi, H | 1 |
| Chino, T | 1 |
| Hasegawa, M | 1 |
| Chen, AC | 1 |
| Damian, DL | 1 |
| Tajiri, K | 1 |
| Nakajima, T | 1 |
| Kawai, K | 1 |
| Minemura, M | 1 |
| Sugiyama, T | 1 |
| Forbat, E | 1 |
| Al-Niaimi, F | 1 |
| Ali, FR | 1 |
| Echeverría, B | 1 |
| Llombart, B | 1 |
| Botella-Estrada, R | 1 |
| Guillén, C | 1 |
| Maki, N | 1 |
| Komine, M | 1 |
| Takatsuka, Y | 1 |
| Maekawa, T | 1 |
| Murata, S | 1 |
| Ohtsuki, M | 1 |
| Niren, NM | 1 |
| Chaffins, ML | 1 |
| Collison, D | 1 |
| Fivenson, DP | 2 |
| Pasmans, SG | 1 |
| Preesman, AH | 1 |
| van Vloten, WA | 1 |
| Yomada, M | 1 |
| Komai, A | 1 |
| Hashimato, T | 1 |
| Khanna, N | 1 |
| Pandhi, RK | 1 |
| Gupta, S | 1 |
| Singh, MK | 1 |
| Peoples, D | 1 |
| Berk, MA | 1 |
| Lorincz, AL | 1 |
| Duschet, P | 1 |
| Schwarz, T | 1 |
| Gschnait, F | 1 |
3 reviews available for niacinamide and Bullous Dermatoses
| Article | Year |
|---|---|
Nicotinamide and the skin.
Topics: Acne Vulgaris; Animals; Autoimmune Diseases; Carcinogenesis; Dermatitis, Atopic; Humans; Keratosis, | 2014 |
Use of nicotinamide in dermatology.
Topics: Acne Vulgaris; Dermatitis, Atopic; Humans; Niacinamide; Pigmentation Disorders; Pruritus; Skin Disea | 2017 |
Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review.
Topics: Acne Vulgaris; Anti-Inflammatory Agents; Drug Combinations; Humans; Immunoglobulin A; Niacinamide; R | 2006 |
11 other studies available for niacinamide and Bullous Dermatoses
| Article | Year |
|---|---|
Successful treatment of recalcitrant subcorneal pustular dermatosis with oral nicotinamide.
Topics: Administration, Oral; Back; Dose-Response Relationship, Drug; Groin; Humans; Male; Middle Aged; Niac | 2019 |
Sneddon-Wilkinson disease induced by sorafenib in a patient with advanced hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Niacinamide; | 2015 |
[Palmoplantar cutaneous reaction to sorafenib].
Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Foot Dermatoses; Hand Dermatoses; Humans; | 2009 |
Pustular eruption induced by sorafenib in a case of psoriasis vulgaris.
Topics: Aged; Asian People; Humans; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Psor | 2013 |
Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases.
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Humans; Immunoglobulin A; Male; M | 1993 |
[Pellagra (deficiency of vitamin B3 or of the amino acid tryptophan): a disease still extant in the Netherlands].
Topics: Alcoholism; Amino Acids, Essential; Dietary Proteins; Female; Humans; Middle Aged; Niacinamide; Pell | 1998 |
Sublamina densa-type linear IgA bullous dermatosis successfully treated with oral tetracycline and niacianamide.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Immuno | 1999 |
Response of chronic bullous dermatosis of childhood to a combination of dapsone and nicotinamide.
Topics: Child, Preschool; Chronic Disease; Dapsone; Drug Therapy, Combination; Female; Humans; Immunoglobuli | 2001 |
Linear IgA bullous dermatosis: successful treatment with tetracycline and nicotinamide.
Topics: Aged; Drug Therapy, Combination; Female; Humans; Immunoglobulin A; Niacinamide; Skin Diseases, Vesic | 1992 |
The treatment of bullous pemphigoid with tetracycline and niacinamide. A preliminary report.
Topics: Administration, Oral; Aged; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Niacinami | 1986 |
Bullous pemphigoid after radiation therapy.
Topics: Aged; Diagnosis, Differential; Humans; Lymecycline; Lymphatic Metastasis; Male; Niacinamide; Pemphig | 1988 |